Gastrointestinal bacterial overgrowth: Pathogenesis and clinical significance

Therapeutic Advances in Chronic Disease

Volumn 4, Issue 5, 2013, Pages 223-231

  Sachdev, Amit H ^a   Pimentel, Mark ^a  

^a CEDARS SINAI MEDICAL CENTER   (United States)

Author keywords

Motility disorder; Small intestinal bacterial overgrowth; Testing; Treatment

Indexed keywords

ARTICLE; BACTERIAL OVERGROWTH; BACTERIUM COLONY; BREATH ANALYSIS; COMPUTER ASSISTED TOMOGRAPHY; DISEASE ASSOCIATION; DISEASE ERADICATION; DISEASE PREDISPOSITION; GASTROESOPHAGEAL REFLUX; HUMAN; HYDROGEN BREATH TEST; INTESTINE FLORA; IRRITABLE COLON; PREVALENCE; PRIORITY JOURNAL;

EID: 84890209945     PISSN: 20406223     EISSN: 20406231     Source Type: Journal    
DOI: 10.1177/2040622313496126     Document Type: Article

References (58)

1. Attar A. Flourie B. Rambaud J. Franchisseur C. Ruszniewski P. Bouhnik Y. (1999) Antibiotic efficacy in small intestinal bacterial overgrowth-related chronic diarrhea: a crossover, randomized trial. Gastroenterology 117: 794–797.
2. Berlin R. (1987) Pica, paper and porphyria. Lancet 2: 1335.
3. Bond J. Jr Levitt M. (1972) Use of pulmonary hydrogen (H 2 ) measurements to quantitate carbohydrate absorption. Study of partially gastrectomized patients. J Clin Invest 51: 1219–1225.
4. Bongaerts G. Tolboom J. Naber A. Sperl W. Severijnen R. Bakkeren J. et al. (1997) Role of bacteria in the pathogenesis of short bowel syndrome-associated d-lactic acidemia. Microb Pathog 22: 285–293.
5. Bouhnik Y. Alain S. Attar A. Flourie B. Raskine L. Sanson-Le Pors M. et al. (1999) Bacterial populations contaminating the upper gut in patients with small intestinal bacterial overgrowth syndrome. Am J Gastroenterol 94: 1327–1331.
6. Bures J. Cyrany J. Kohoutova D. Forstl M. Rejchrt S. Kvetina J. et al. (2010) Small Intestinal bacterial overgrowth syndrome. World J Gastroenterol 16: 2978–2990.
7. Cole C. Ziegler T. (2007) Small Bowel bacterial overgrowth: a negative factor in gut adaptation in pediatric SBS. Curr Gastroenterol Rep 9: 456–462.
8. Compare D. Coccoli P. Rocco A. Nardone O. de Maria S. Carteni M. et al. (2012) Gut–liver axis: the impact of gut microbiota on non alcoholic fatty liver disease. Nutr Metab Cardiovasc Dis 22: 471–476.
9. Compare D. Pica L. Rocco A. de Giorgi F. Cuomo R. Sarnelli G. et al. (2011) Effects of long-term PPI treatment on producing bowel symptoms and SIBO. Eur J Clin Invest 41: 380–386.
10. Di Stefano M. Strocchi A. Malservisi S. Veneto G. Ferrieri A. Corazza G. (2000) Non-absorbable antibiotics for managing intestinal gas production and gas-related symptoms. Aliment Pharmacol Ther 14: 1001–1008.
11. Di Stefano M. Veneto G. Malservisi S. Corazza G. (2001) Small intestine bacterial overgrowth and metabolic bone disease. Dig Dis Sci 46: 1077–1082.
12. Fan X. Sellin J. (2009) Review article: small intestinal bacterial overgrowth, bile acid malabsorption and gluten intolerance as possible causes of chronic watery diarrhoea. Aliment Pharmacol Ther 29: 1069–1077.
13. Frank D. St Amand A. Feldman R. Boedeker E. Harpaz N. Pace N. (2007) Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases. Proc Natl Acad Sci U S A 104: 13780–13785.
14. Frissora C. Cash B. (2007) Review article: the role of antibiotics vs. conventional pharmacotherapy in treating symptoms of irritable bowel syndrome. Aliment Pharmacol Ther 25: 1271–1281.
15. Fumi A. Trexler K. (2008) Rifaximin treatment for symptoms of irritable bowel syndrome. Ann Pharmacother 42: 408–412.
16. Funayama Y. Sasaki I. Naito H. Fukushima K. Shibata C. Masuko T. et al. (1999) Monitoring and antibacterial treatment for postoperative bacterial overgrowth in Crohn's disease. Dis Colon Rectum 42: 1072–1077.
17. Gasbarrini A. Lauritano E. Gabrielli M. Scarpellini E. Lupascu A. Ojetti V. et al. (2007) Small intestinal bacterial overgrowth: diagnosis and treatment. Dig Dis 25: 237–240.
18. Ghoshal U. Ghoshal U. Misra A. Choudhuri G. (2004) Partially responsive celiac disease resulting from small intestinal bacterial overgrowth and lactose intolerance. BMC Gastroenterol 4: 10.
19. Ghoshal U. Ghoshal U. Ranjan P. Naik S. Ayyagari A. (2003) Spectrum and antibiotic sensitivity of bacteria contaminating the upper gut in patients with malabsorption syndrome from the tropics. BMC Gastroenterol 3: 9.
20. Giannella R. Toskes P. (1976) Gastrointestinal bleeding and iron absorption in the experimental blind loop syndrome. Am J Clin Nutr 29: 754–757.
21. Hamvas J. (2012) [Proton-pump inhibitor therapy and small bowel bacterial contamination]. Orv Hetil 153: 1287–1293.
22. Kerlin P. Wong L. (1988) Breath hydrogen testing in bacterial overgrowth of the small intestine. Gastroenterology 95: 982–988.
23. Khoshini R. Dai S. Lezcano S. Pimentel M. (2008) A Systematic review of diagnostic tests for small intestinal bacterial overgrowth. Dig Dis Sci 53: 1443–1454.
24. King C. Toskes P. (1986) Comparison of the 1-gram [14C]xylose, 10-gram lactulose-H2, and 80-gram glucose-H2 breath tests in patients with small intestine bacterial overgrowth. Gastroenterology 91: 1447–1451.
25. Koo H. Dupont H. (2010) Rifaximin: a unique gastrointestinal-selective antibiotic for enteric diseases. Curr Opin Gastroenterol 26: 17–25.
26. Krauss N. Schuppan D. (2006) Monitoring nonresponsive patients who have celiac disease. Gastrointest Endosc Clin N Am 16: 317–327.
27. Krishnamurthy S. Kelly M. Rohrmann C. Schuffler M. (1983) Jejunal diverticulosis. A heterogenous disorder caused by a variety of abnormalities of smooth muscle or myenteric plexus. Gastroenterology 85: 538–547.
28. Lauritano E. Gabrielli M. Scarpellini E. Lupascu A. Novi M. Sottili S. et al. (2008) Small intestinal bacterial overgrowth recurrence after antibiotic therapy. Am J Gastroenterol 103: 2031–2035.
29. Lin H. (2004) Small intestinal bacterial overgrowth: a framework for understanding irritable bowel syndrome. JAMA 292: 852–858.
30. Lombardo L. Foti M. Ruggia O. Chiecchio A. (2010) Increased incidence of small intestinal bacterial overgrowth during proton pump inhibitor therapy. Clin Gastroenterol Hepatol 8: 504–508.
31. Lupascu A. Gabrielli M. Lauritano E. Scarpellini E. Santoliquido A. Cammarota G. et al. (2005) Hydrogen glucose breath test to detect small intestinal bacterial overgrowth: a prevalence case-control study in irritable bowel syndrome. Aliment Pharmacol Ther 22: 1157–1160.
32. Machado M. Cortez-Pinto H. (2012) Gut microbiota and nonalcoholic fatty liver disease. Ann Hepatol 11: 440–449.
33. Malik B. Xie Y. Wine E. Huynh H. (2011) Diagnosis and pharmacological management of small intestinal bacterial overgrowth in children with intestinal failure. Can J Gastroenterol 25: 41–45.
34. Pande C. Kumar A. Sarin S. (2009) Small-intestinal bacterial overgrowth in cirrhosis is related to the severity of liver disease. Aliment Pharmacol Ther 29: 1273–1281.
35. Parodi A. Paolino S. Greco A. Drago F. Mansi C. Rebora A. et al. (2008) Small intestinal bacterial overgrowth in rosacea: clinical effectiveness of its eradication. Clin Gastroenterol Hepatol 6: 759–764.
36. Parodi A. Sessarego M. Greco A. Bazzica M. Filaci G. Setti M. et al. (2008) Small intestinal bacterial overgrowth in patients suffering from scleroderma: clinical effectiveness of its eradication. Am J Gastroenterol 103: 1257–1262.
37. Pimentel M. Chow E. Lin H. (2000) Eradication of small intestinal bacterial overgrowth reduces symptoms of irritable bowel syndrome. Am J Gastroenterol 95: 3503–3506.
38. Pimentel M. Lezcano S. (2007) Irritable bowel syndrome: bacterial overgrowth–what's known and what to do. Curr Treat Options Gastroenterol 10: 328–337.
39. Pimentel M. Morales W. Chua K. Barlow G. Weitsman S. Kim G. et al. (2011) Effects of rifaximin treatment and retreatment in nonconstipated ibs subjects. Dig Dis Sci 56: 2067–2072.
40. Pimentel M. Park S. Mirocha J. Kane S. Kong Y. (2006) The effect of a nonabsorbed oral antibiotic (rifaximin) on the symptoms of the irritable bowel syndrome: a randomized trial. Ann Intern Med 145: 557–563.
41. Posserud I. Stotzer P. Bjornsson E. Abrahamsson H. Simren M. (2007) Small intestinal bacterial overgrowth in patients with irritable bowel syndrome. Gut 56: 802–808.
42. Quigley E. Abu-Shanab A. (2010) Small intestinal bacterial overgrowth. Infect Dis Clin North Am 24: 943–959, viii–ix.
43. Rabenstein T. Fromm M. Zolk O. (2011) [Rifaximin–a non-resorbable antibiotic with many indications in gastroenterology]. Z Gastroenterol 49: 211–224.
44. Riordan S. McIver C. Duncombe V. Bolin T. Thomas M. (1995) Factors Influencing the 1-g 14C-d-xylose breath test for bacterial overgrowth. Am J Gastroenterol 90: 1455–1460.
45. Riordan S. McIver C. Walker B. Duncombe V. Bolin T. Thomas M. (1996) The lactulose breath hydrogen test and small intestinal bacterial overgrowth. Am J Gastroenterol 91: 1795–1803.
46. Rubio-Tapia A. Barton S. Rosenblatt J. Murray J. (2009) Prevalence of small intestine bacterial overgrowth diagnosed by quantitative culture of intestinal aspirate in celiac disease. J Clin Gastroenterol 43: 157–161.
47. Sabate J. Jouet P. Harnois F. Mechler C. Msika S. Grossin M. et al. (2008) High prevalence of small intestinal bacterial overgrowth in patients with morbid obesity: a contributor to severe hepatic steatosis. Obes Surg 18: 371–377.
48. Sachdev A. Pimentel M. (2012) Antibiotics for irritable bowel syndrome: rationale and current evidence. Curr Gastroenterol Rep 14: 439–445.
49. Savage D. (1977) Microbial ecology of the gastrointestinal tract. Annu Rev Microbiol 31: 107–133.
50. Simren M. Barbara G. Flint H. Spiegel B. Spiller R. Vanner S. et al. (2013) Intestinal microbiota in functional bowel disorders: a Rome Foundation report. Gut 62: 159–176.
51. Singh V. Toskes P. (2004) Small bowel bacterial overgrowth: presentation, diagnosis, and treatment. Curr Treat Options Gastroenterol 7: 19–28.
52. Stotzer P. Kilander A. (2000) Comparison of the 1-gram (14)C-d-xylose breath test and the 50-gram hydrogen glucose breath test for diagnosis of small intestinal bacterial overgrowth. Digestion 61: 165–171.
53. Taylor S. Sondheimer J. Sokol R. Silverman A. Wilson H. (1991) Noninfectious colitis associated with short gut syndrome in infants. J Pediatr 119: 24–28.
54. Toskes P. (1993) Bacterial overgrowth of the gastrointestinal tract. Adv Intern Med 38: 387–407.
55. Trespi E. Ferrieri A. (1999) Intestinal bacterial overgrowth during chronic pancreatitis. Curr Med Res Opin 15: 47–52.
56. Vanderhoof J. Young R. Murray N. Kaufman S. (1998) Treatment strategies for small bowel bacterial overgrowth in short bowel syndrome. J Pediatr Gastroenterol Nutr 27: 155–160.
57. Weinstock L. Walters A. (2011) Restless legs syndrome is associated with irritable bowel syndrome and small intestinal bacterial overgrowth. Sleep Med 12: 610–613.
58. Yang J. Lee H. Low K. Chatterjee S. Pimentel M. (2008) Rifaximin versus other antibiotics in the primary treatment and retreatment of bacterial overgrowth in IBS. Dig Dis Sci 53: 169–174.